The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Booher, J., & Sensenbrenner, M. (1972) · PubMed · Cited by 760
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 547
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Self-citationSignificant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Self-citationIn vitro model for evaluating drug transport across the blood–brain barrier
Cecchelli, R., Dehouck, B., Descamps, L., Fenart, L., Buée-Scherrer, V, Duhem, C., Lundquist, S., Rentfel, M., Torpier, G., & Dehouck, M. P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00083-0 · Cited by 383
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Self-citationDrug Transfer Across the Blood‐Brain Barrier: Correlation Between In Vitro and In Vivo Models
Dehouck, M., Jolliet‐Riant, P., Brée, F., Fruchart, J., Cecchelli, R., & Tillement, J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10055.x · Cited by 286
Molecular sieving characteristics of the cultured endothelial monolayer
Siflinger‐Birnboim, A., del Vecchio, P. J., Cooper, J. A., Blumenstock, F. A., Shepard, J. M., & Malik, A. B. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041320115 · Cited by 256
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Self-citationOlivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213
Méresse, S., Dehouck, M., Delorme, P., Bensaïd, M., Tauber, J., Delbart, C., Fruchart, J., & Cecchelli, R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb08526.x · Cited by 204
Ramge, P., Unger, R. E., Oltrogge, J. B., Zenker, D., Begley, D., Kreuter, J., & Von Briesen, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00078.x · Cited by 197
Self-citationGelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, S. E., Turowski, B., Zanella, F. E., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185
Self-citationAlyaudtin, R. N., Reichel, A., Löbenberg, R., Ramge, P., Kreuter, J., & Begley, D. J. (2001) · Journal of Drug Targeting · doi:10.3109/10611860108997929 · Cited by 166
Self-citationCulture and characterization of microvascular endothelial cells derived from human brain.
Dorovini‐Zis, K., Prameya, R., & Bowman, P. D. (1991) · PubMed · Cited by 163
Raub, T. J., Kuentzel, S. L., & Sawada, G. A. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90442-b · Cited by 161
Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148
Self-citationSchröder, U., & Sabel, B. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01375-x · Cited by 141
Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 139
Toxicity of Polyalkylcyanoacrylate Nanoparticles I: Free Nanoparticles
Kante, B., Couvreur, P., Dubois-Krack, G., de Meester, C., Guiot, P., Roland, M., Mercier, M., & Speiseru, P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710716 · Cited by 121
The Blood-Brain Barrier and Drug Delivery to the CNS
(2000) · CRC Press eBooks · doi:10.1201/9780824741990 · Cited by 93
Ramge, P., Kreuter, J., & Lemmer, B. (1999) · Chronobiology International · doi:10.3109/07420529909016944 · Cited by 29
Self-citationONTOGENY OF THE ULTRADIAN RHYTHM OF ACTIVITY IN JAPANESE QUAIL
Lumineau, S., Guyomarc’h, C., & Richard, J. (2000) · Chronobiology International · doi:10.1081/cbi-100102112 · Cited by 19
Using Nanoparticles to Target Drugs to the Central Nervous System
Alyautdin, R. N., & Kreuter, J. (2000) · CRC Press eBooks · doi:10.1201/9780824741990.ch11 · Cited by 12
Self-citationDrug Metabolism in the Brain: Benefits and Risks
El-Bachá, R. D. S., Lagrange, P., Grădinaru, D., Suleman, F. G., Minn, A., & Denizot, C. (2000) · CRC Press eBooks · doi:10.1201/9780824741990.ch9 · Cited by 9
Cited by
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Applications of nanoparticles in biology and medicine
Salata, O. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-3 · Cited by 2,327
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Metadata
- Authors
- Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J.
- Venue
- Pharmaceutical Research
- Published
- 2003-03
- Volume
- 20
- Issue
- 3
- Pages
- 409-416
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1553061387
- Cited by
- 469
- References
- 25
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.